Prothena reported $600.1M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 94.64M 172.32M
Adamas Pharmaceuticals ADMS:US 78.62M 10.17M
Agios Pharmaceuticals AGIO:US $ 400.22M 568.9M
Akebia Therapeutics AKBA:US $ 207.2M 39.79M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
ALKERMES ALKS:US $ 310.44M 52.1M
Alnylam Pharmaceuticals ALNY:US $ 1093.99M 348.22M
Amgen AMGN:US $ 11969M 5339M
Biogen BIIB:US $ 1541.8M 200.2M
Biomarin Pharmaceutical BMRN:US $ 617.14M 24.39M
Bluebird Bio BLUE:US $ 402.46M 48.99M
Exelixis EXEL:US $ 567.33M 74.86M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Intercept Pharmaceuticals ICPT:US $ 428.77M 283.15M
Intra Cellular Therapies ITCI:US $ 106.13M 14.9M
IONIS PHARMACEUT IONS:US $ 1987M 1421.88M
Macrogenics MGNX:US $ 190.53M 1.56M
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Neurocrine Biosciences NBIX:US $ 311.1M 56.9M
Prothena PRTA:US $ 600.1M 200.27M
Regeneron Pharmaceuticals REGN:US $ 3432.4M 1360.2M
Seattle Genetics SGEN:US $ 685.17M 271.74M
Ultragenyx Pharmaceutical RARE:US $ 197.54M 93.34M
Vertex Pharmaceuticals VRTX:US $ 6275.7M 212.02M
Vital Therapies VTL:US $ 110.44M 23.27M
YTE INCY:US $ 1999.02M 201.44M